Global Anti-radiation Drugs Supply, Demand and Key Producers, 2023-2029
The global Anti-radiation Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Anti-radiation drugs offer protection against radiation exposure. These drugs include Kl,Prussian Blue, and DTPA (Diethylenetriamine pentaacetate). Anti-radiation medicines help block the absorption and subsequent concentration of radioactive iodine in the thyroid gland. KI must be consumed before or shortly after exposure to radioactive iodine for better results.It is effective only against radioactive iodine and not against other types of radiation. Oxidation of ferrous ferrocyanide salts produces Prussian blue that is used for the treatment of thallium poisoning or radioactive cesium poisoning.
This report studies the global Anti-radiation Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-radiation Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-radiation Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-radiation Drugs total production and demand, 2018-2029, (K Units)
Global Anti-radiation Drugs total production value, 2018-2029, (USD Million)
Global Anti-radiation Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-radiation Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Anti-radiation Drugs domestic production, consumption, key domestic manufacturers and share
Global Anti-radiation Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Anti-radiation Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-radiation Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Anti-radiation Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics and Mission Pharmacal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-radiation Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Anti-radiation Drugs Market, By Region:
1. How big is the global Anti-radiation Drugs market?
2. What is the demand of the global Anti-radiation Drugs market?
3. What is the year over year growth of the global Anti-radiation Drugs market?
4. What is the production and production value of the global Anti-radiation Drugs market?
5. Who are the key producers in the global Anti-radiation Drugs market?
Anti-radiation drugs offer protection against radiation exposure. These drugs include Kl,Prussian Blue, and DTPA (Diethylenetriamine pentaacetate). Anti-radiation medicines help block the absorption and subsequent concentration of radioactive iodine in the thyroid gland. KI must be consumed before or shortly after exposure to radioactive iodine for better results.It is effective only against radioactive iodine and not against other types of radiation. Oxidation of ferrous ferrocyanide salts produces Prussian blue that is used for the treatment of thallium poisoning or radioactive cesium poisoning.
This report studies the global Anti-radiation Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-radiation Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-radiation Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-radiation Drugs total production and demand, 2018-2029, (K Units)
Global Anti-radiation Drugs total production value, 2018-2029, (USD Million)
Global Anti-radiation Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-radiation Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Anti-radiation Drugs domestic production, consumption, key domestic manufacturers and share
Global Anti-radiation Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Anti-radiation Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-radiation Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Anti-radiation Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics and Mission Pharmacal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-radiation Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Anti-radiation Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Potassium lodide (KI)
- Prussian Blue
- DTPA (Diethylenetriamine Pentaacetate)
- Others
- Acute Radiation Syndrome(ARS)
- Cancer Treatment
- Radiation Exposure
- Others
- Amgen
- Anbex
- BTG International
- Cellphire
- Chrysalis BioTherapeutics
- Darnitsa
- Enzychem Lifesciences
- Humanetics
- Mission Pharmacal
- Partner Therapeutics
- Myelo Therapeutics
- Pluri
1. How big is the global Anti-radiation Drugs market?
2. What is the demand of the global Anti-radiation Drugs market?
3. What is the year over year growth of the global Anti-radiation Drugs market?
4. What is the production and production value of the global Anti-radiation Drugs market?
5. Who are the key producers in the global Anti-radiation Drugs market?
1 SUPPLY SUMMARY
1.1 Anti-radiation Drugs Introduction
1.2 World Anti-radiation Drugs Supply & Forecast
1.2.1 World Anti-radiation Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Anti-radiation Drugs Production (2018-2029)
1.2.3 World Anti-radiation Drugs Pricing Trends (2018-2029)
1.3 World Anti-radiation Drugs Production by Region (Based on Production Site)
1.3.1 World Anti-radiation Drugs Production Value by Region (2018-2029)
1.3.2 World Anti-radiation Drugs Production by Region (2018-2029)
1.3.3 World Anti-radiation Drugs Average Price by Region (2018-2029)
1.3.4 North America Anti-radiation Drugs Production (2018-2029)
1.3.5 Europe Anti-radiation Drugs Production (2018-2029)
1.3.6 China Anti-radiation Drugs Production (2018-2029)
1.3.7 Japan Anti-radiation Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-radiation Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-radiation Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-radiation Drugs Demand (2018-2029)
2.2 World Anti-radiation Drugs Consumption by Region
2.2.1 World Anti-radiation Drugs Consumption by Region (2018-2023)
2.2.2 World Anti-radiation Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Anti-radiation Drugs Consumption (2018-2029)
2.4 China Anti-radiation Drugs Consumption (2018-2029)
2.5 Europe Anti-radiation Drugs Consumption (2018-2029)
2.6 Japan Anti-radiation Drugs Consumption (2018-2029)
2.7 South Korea Anti-radiation Drugs Consumption (2018-2029)
2.8 ASEAN Anti-radiation Drugs Consumption (2018-2029)
2.9 India Anti-radiation Drugs Consumption (2018-2029)
3 WORLD ANTI-RADIATION DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-radiation Drugs Production Value by Manufacturer (2018-2023)
3.2 World Anti-radiation Drugs Production by Manufacturer (2018-2023)
3.3 World Anti-radiation Drugs Average Price by Manufacturer (2018-2023)
3.4 Anti-radiation Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-radiation Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-radiation Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Anti-radiation Drugs in 2022
3.6 Anti-radiation Drugs Market: Overall Company Footprint Analysis
3.6.1 Anti-radiation Drugs Market: Region Footprint
3.6.2 Anti-radiation Drugs Market: Company Product Type Footprint
3.6.3 Anti-radiation Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-radiation Drugs Production Value Comparison
4.1.1 United States VS China: Anti-radiation Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Anti-radiation Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Anti-radiation Drugs Production Comparison
4.2.1 United States VS China: Anti-radiation Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Anti-radiation Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Anti-radiation Drugs Consumption Comparison
4.3.1 United States VS China: Anti-radiation Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Anti-radiation Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Anti-radiation Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-radiation Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Anti-radiation Drugs Production (2018-2023)
4.5 China Based Anti-radiation Drugs Manufacturers and Market Share
4.5.1 China Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-radiation Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Anti-radiation Drugs Production (2018-2023)
4.6 Rest of World Based Anti-radiation Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-radiation Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Anti-radiation Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-radiation Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Potassium lodide (KI)
5.2.2 Prussian Blue
5.2.3 DTPA (Diethylenetriamine Pentaacetate)
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Anti-radiation Drugs Production by Type (2018-2029)
5.3.2 World Anti-radiation Drugs Production Value by Type (2018-2029)
5.3.3 World Anti-radiation Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Anti-radiation Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Acute Radiation Syndrome(ARS)
6.2.2 Cancer Treatment
6.2.3 Radiation Exposure
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Anti-radiation Drugs Production by Application (2018-2029)
6.3.2 World Anti-radiation Drugs Production Value by Application (2018-2029)
6.3.3 World Anti-radiation Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Anti-radiation Drugs Product and Services
7.1.4 Amgen Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Anbex
7.2.1 Anbex Details
7.2.2 Anbex Major Business
7.2.3 Anbex Anti-radiation Drugs Product and Services
7.2.4 Anbex Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Anbex Recent Developments/Updates
7.2.6 Anbex Competitive Strengths & Weaknesses
7.3 BTG International
7.3.1 BTG International Details
7.3.2 BTG International Major Business
7.3.3 BTG International Anti-radiation Drugs Product and Services
7.3.4 BTG International Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BTG International Recent Developments/Updates
7.3.6 BTG International Competitive Strengths & Weaknesses
7.4 Cellphire
7.4.1 Cellphire Details
7.4.2 Cellphire Major Business
7.4.3 Cellphire Anti-radiation Drugs Product and Services
7.4.4 Cellphire Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Cellphire Recent Developments/Updates
7.4.6 Cellphire Competitive Strengths & Weaknesses
7.5 Chrysalis BioTherapeutics
7.5.1 Chrysalis BioTherapeutics Details
7.5.2 Chrysalis BioTherapeutics Major Business
7.5.3 Chrysalis BioTherapeutics Anti-radiation Drugs Product and Services
7.5.4 Chrysalis BioTherapeutics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Chrysalis BioTherapeutics Recent Developments/Updates
7.5.6 Chrysalis BioTherapeutics Competitive Strengths & Weaknesses
7.6 Darnitsa
7.6.1 Darnitsa Details
7.6.2 Darnitsa Major Business
7.6.3 Darnitsa Anti-radiation Drugs Product and Services
7.6.4 Darnitsa Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Darnitsa Recent Developments/Updates
7.6.6 Darnitsa Competitive Strengths & Weaknesses
7.7 Enzychem Lifesciences
7.7.1 Enzychem Lifesciences Details
7.7.2 Enzychem Lifesciences Major Business
7.7.3 Enzychem Lifesciences Anti-radiation Drugs Product and Services
7.7.4 Enzychem Lifesciences Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Enzychem Lifesciences Recent Developments/Updates
7.7.6 Enzychem Lifesciences Competitive Strengths & Weaknesses
7.8 Humanetics
7.8.1 Humanetics Details
7.8.2 Humanetics Major Business
7.8.3 Humanetics Anti-radiation Drugs Product and Services
7.8.4 Humanetics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Humanetics Recent Developments/Updates
7.8.6 Humanetics Competitive Strengths & Weaknesses
7.9 Mission Pharmacal
7.9.1 Mission Pharmacal Details
7.9.2 Mission Pharmacal Major Business
7.9.3 Mission Pharmacal Anti-radiation Drugs Product and Services
7.9.4 Mission Pharmacal Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mission Pharmacal Recent Developments/Updates
7.9.6 Mission Pharmacal Competitive Strengths & Weaknesses
7.10 Partner Therapeutics
7.10.1 Partner Therapeutics Details
7.10.2 Partner Therapeutics Major Business
7.10.3 Partner Therapeutics Anti-radiation Drugs Product and Services
7.10.4 Partner Therapeutics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Partner Therapeutics Recent Developments/Updates
7.10.6 Partner Therapeutics Competitive Strengths & Weaknesses
7.11 Myelo Therapeutics
7.11.1 Myelo Therapeutics Details
7.11.2 Myelo Therapeutics Major Business
7.11.3 Myelo Therapeutics Anti-radiation Drugs Product and Services
7.11.4 Myelo Therapeutics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Myelo Therapeutics Recent Developments/Updates
7.11.6 Myelo Therapeutics Competitive Strengths & Weaknesses
7.12 Pluri
7.12.1 Pluri Details
7.12.2 Pluri Major Business
7.12.3 Pluri Anti-radiation Drugs Product and Services
7.12.4 Pluri Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pluri Recent Developments/Updates
7.12.6 Pluri Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-radiation Drugs Industry Chain
8.2 Anti-radiation Drugs Upstream Analysis
8.2.1 Anti-radiation Drugs Core Raw Materials
8.2.2 Main Manufacturers of Anti-radiation Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-radiation Drugs Production Mode
8.6 Anti-radiation Drugs Procurement Model
8.7 Anti-radiation Drugs Industry Sales Model and Sales Channels
8.7.1 Anti-radiation Drugs Sales Model
8.7.2 Anti-radiation Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Anti-radiation Drugs Introduction
1.2 World Anti-radiation Drugs Supply & Forecast
1.2.1 World Anti-radiation Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Anti-radiation Drugs Production (2018-2029)
1.2.3 World Anti-radiation Drugs Pricing Trends (2018-2029)
1.3 World Anti-radiation Drugs Production by Region (Based on Production Site)
1.3.1 World Anti-radiation Drugs Production Value by Region (2018-2029)
1.3.2 World Anti-radiation Drugs Production by Region (2018-2029)
1.3.3 World Anti-radiation Drugs Average Price by Region (2018-2029)
1.3.4 North America Anti-radiation Drugs Production (2018-2029)
1.3.5 Europe Anti-radiation Drugs Production (2018-2029)
1.3.6 China Anti-radiation Drugs Production (2018-2029)
1.3.7 Japan Anti-radiation Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-radiation Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-radiation Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-radiation Drugs Demand (2018-2029)
2.2 World Anti-radiation Drugs Consumption by Region
2.2.1 World Anti-radiation Drugs Consumption by Region (2018-2023)
2.2.2 World Anti-radiation Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Anti-radiation Drugs Consumption (2018-2029)
2.4 China Anti-radiation Drugs Consumption (2018-2029)
2.5 Europe Anti-radiation Drugs Consumption (2018-2029)
2.6 Japan Anti-radiation Drugs Consumption (2018-2029)
2.7 South Korea Anti-radiation Drugs Consumption (2018-2029)
2.8 ASEAN Anti-radiation Drugs Consumption (2018-2029)
2.9 India Anti-radiation Drugs Consumption (2018-2029)
3 WORLD ANTI-RADIATION DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-radiation Drugs Production Value by Manufacturer (2018-2023)
3.2 World Anti-radiation Drugs Production by Manufacturer (2018-2023)
3.3 World Anti-radiation Drugs Average Price by Manufacturer (2018-2023)
3.4 Anti-radiation Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-radiation Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-radiation Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Anti-radiation Drugs in 2022
3.6 Anti-radiation Drugs Market: Overall Company Footprint Analysis
3.6.1 Anti-radiation Drugs Market: Region Footprint
3.6.2 Anti-radiation Drugs Market: Company Product Type Footprint
3.6.3 Anti-radiation Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-radiation Drugs Production Value Comparison
4.1.1 United States VS China: Anti-radiation Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Anti-radiation Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Anti-radiation Drugs Production Comparison
4.2.1 United States VS China: Anti-radiation Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Anti-radiation Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Anti-radiation Drugs Consumption Comparison
4.3.1 United States VS China: Anti-radiation Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Anti-radiation Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Anti-radiation Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-radiation Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Anti-radiation Drugs Production (2018-2023)
4.5 China Based Anti-radiation Drugs Manufacturers and Market Share
4.5.1 China Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-radiation Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Anti-radiation Drugs Production (2018-2023)
4.6 Rest of World Based Anti-radiation Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-radiation Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Anti-radiation Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-radiation Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Potassium lodide (KI)
5.2.2 Prussian Blue
5.2.3 DTPA (Diethylenetriamine Pentaacetate)
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Anti-radiation Drugs Production by Type (2018-2029)
5.3.2 World Anti-radiation Drugs Production Value by Type (2018-2029)
5.3.3 World Anti-radiation Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Anti-radiation Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Acute Radiation Syndrome(ARS)
6.2.2 Cancer Treatment
6.2.3 Radiation Exposure
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Anti-radiation Drugs Production by Application (2018-2029)
6.3.2 World Anti-radiation Drugs Production Value by Application (2018-2029)
6.3.3 World Anti-radiation Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Anti-radiation Drugs Product and Services
7.1.4 Amgen Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Anbex
7.2.1 Anbex Details
7.2.2 Anbex Major Business
7.2.3 Anbex Anti-radiation Drugs Product and Services
7.2.4 Anbex Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Anbex Recent Developments/Updates
7.2.6 Anbex Competitive Strengths & Weaknesses
7.3 BTG International
7.3.1 BTG International Details
7.3.2 BTG International Major Business
7.3.3 BTG International Anti-radiation Drugs Product and Services
7.3.4 BTG International Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BTG International Recent Developments/Updates
7.3.6 BTG International Competitive Strengths & Weaknesses
7.4 Cellphire
7.4.1 Cellphire Details
7.4.2 Cellphire Major Business
7.4.3 Cellphire Anti-radiation Drugs Product and Services
7.4.4 Cellphire Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Cellphire Recent Developments/Updates
7.4.6 Cellphire Competitive Strengths & Weaknesses
7.5 Chrysalis BioTherapeutics
7.5.1 Chrysalis BioTherapeutics Details
7.5.2 Chrysalis BioTherapeutics Major Business
7.5.3 Chrysalis BioTherapeutics Anti-radiation Drugs Product and Services
7.5.4 Chrysalis BioTherapeutics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Chrysalis BioTherapeutics Recent Developments/Updates
7.5.6 Chrysalis BioTherapeutics Competitive Strengths & Weaknesses
7.6 Darnitsa
7.6.1 Darnitsa Details
7.6.2 Darnitsa Major Business
7.6.3 Darnitsa Anti-radiation Drugs Product and Services
7.6.4 Darnitsa Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Darnitsa Recent Developments/Updates
7.6.6 Darnitsa Competitive Strengths & Weaknesses
7.7 Enzychem Lifesciences
7.7.1 Enzychem Lifesciences Details
7.7.2 Enzychem Lifesciences Major Business
7.7.3 Enzychem Lifesciences Anti-radiation Drugs Product and Services
7.7.4 Enzychem Lifesciences Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Enzychem Lifesciences Recent Developments/Updates
7.7.6 Enzychem Lifesciences Competitive Strengths & Weaknesses
7.8 Humanetics
7.8.1 Humanetics Details
7.8.2 Humanetics Major Business
7.8.3 Humanetics Anti-radiation Drugs Product and Services
7.8.4 Humanetics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Humanetics Recent Developments/Updates
7.8.6 Humanetics Competitive Strengths & Weaknesses
7.9 Mission Pharmacal
7.9.1 Mission Pharmacal Details
7.9.2 Mission Pharmacal Major Business
7.9.3 Mission Pharmacal Anti-radiation Drugs Product and Services
7.9.4 Mission Pharmacal Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mission Pharmacal Recent Developments/Updates
7.9.6 Mission Pharmacal Competitive Strengths & Weaknesses
7.10 Partner Therapeutics
7.10.1 Partner Therapeutics Details
7.10.2 Partner Therapeutics Major Business
7.10.3 Partner Therapeutics Anti-radiation Drugs Product and Services
7.10.4 Partner Therapeutics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Partner Therapeutics Recent Developments/Updates
7.10.6 Partner Therapeutics Competitive Strengths & Weaknesses
7.11 Myelo Therapeutics
7.11.1 Myelo Therapeutics Details
7.11.2 Myelo Therapeutics Major Business
7.11.3 Myelo Therapeutics Anti-radiation Drugs Product and Services
7.11.4 Myelo Therapeutics Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Myelo Therapeutics Recent Developments/Updates
7.11.6 Myelo Therapeutics Competitive Strengths & Weaknesses
7.12 Pluri
7.12.1 Pluri Details
7.12.2 Pluri Major Business
7.12.3 Pluri Anti-radiation Drugs Product and Services
7.12.4 Pluri Anti-radiation Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pluri Recent Developments/Updates
7.12.6 Pluri Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-radiation Drugs Industry Chain
8.2 Anti-radiation Drugs Upstream Analysis
8.2.1 Anti-radiation Drugs Core Raw Materials
8.2.2 Main Manufacturers of Anti-radiation Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-radiation Drugs Production Mode
8.6 Anti-radiation Drugs Procurement Model
8.7 Anti-radiation Drugs Industry Sales Model and Sales Channels
8.7.1 Anti-radiation Drugs Sales Model
8.7.2 Anti-radiation Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Anti-radiation Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Anti-radiation Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Anti-radiation Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Anti-radiation Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Anti-radiation Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Anti-radiation Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Anti-radiation Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Anti-radiation Drugs Production Market Share by Region (2018-2023)
Table 9. World Anti-radiation Drugs Production Market Share by Region (2024-2029)
Table 10. World Anti-radiation Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Anti-radiation Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Anti-radiation Drugs Major Market Trends
Table 13. World Anti-radiation Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Anti-radiation Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Anti-radiation Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Anti-radiation Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Anti-radiation Drugs Producers in 2022
Table 18. World Anti-radiation Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Anti-radiation Drugs Producers in 2022
Table 20. World Anti-radiation Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Anti-radiation Drugs Company Evaluation Quadrant
Table 22. World Anti-radiation Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Anti-radiation Drugs Production Site of Key Manufacturer
Table 24. Anti-radiation Drugs Market: Company Product Type Footprint
Table 25. Anti-radiation Drugs Market: Company Product Application Footprint
Table 26. Anti-radiation Drugs Competitive Factors
Table 27. Anti-radiation Drugs New Entrant and Capacity Expansion Plans
Table 28. Anti-radiation Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Anti-radiation Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Anti-radiation Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Anti-radiation Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-radiation Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Anti-radiation Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Anti-radiation Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Anti-radiation Drugs Production Market Share (2018-2023)
Table 37. China Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-radiation Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Anti-radiation Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Anti-radiation Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Anti-radiation Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-radiation Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-radiation Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Anti-radiation Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-radiation Drugs Production Market Share (2018-2023)
Table 47. World Anti-radiation Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Anti-radiation Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Anti-radiation Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Anti-radiation Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Anti-radiation Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Anti-radiation Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Anti-radiation Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Anti-radiation Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Anti-radiation Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Anti-radiation Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Anti-radiation Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Anti-radiation Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Anti-radiation Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Anti-radiation Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Anti-radiation Drugs Product and Services
Table 64. Amgen Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Anbex Basic Information, Manufacturing Base and Competitors
Table 68. Anbex Major Business
Table 69. Anbex Anti-radiation Drugs Product and Services
Table 70. Anbex Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Anbex Recent Developments/Updates
Table 72. Anbex Competitive Strengths & Weaknesses
Table 73. BTG International Basic Information, Manufacturing Base and Competitors
Table 74. BTG International Major Business
Table 75. BTG International Anti-radiation Drugs Product and Services
Table 76. BTG International Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BTG International Recent Developments/Updates
Table 78. BTG International Competitive Strengths & Weaknesses
Table 79. Cellphire Basic Information, Manufacturing Base and Competitors
Table 80. Cellphire Major Business
Table 81. Cellphire Anti-radiation Drugs Product and Services
Table 82. Cellphire Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Cellphire Recent Developments/Updates
Table 84. Cellphire Competitive Strengths & Weaknesses
Table 85. Chrysalis BioTherapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Chrysalis BioTherapeutics Major Business
Table 87. Chrysalis BioTherapeutics Anti-radiation Drugs Product and Services
Table 88. Chrysalis BioTherapeutics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Chrysalis BioTherapeutics Recent Developments/Updates
Table 90. Chrysalis BioTherapeutics Competitive Strengths & Weaknesses
Table 91. Darnitsa Basic Information, Manufacturing Base and Competitors
Table 92. Darnitsa Major Business
Table 93. Darnitsa Anti-radiation Drugs Product and Services
Table 94. Darnitsa Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Darnitsa Recent Developments/Updates
Table 96. Darnitsa Competitive Strengths & Weaknesses
Table 97. Enzychem Lifesciences Basic Information, Manufacturing Base and Competitors
Table 98. Enzychem Lifesciences Major Business
Table 99. Enzychem Lifesciences Anti-radiation Drugs Product and Services
Table 100. Enzychem Lifesciences Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Enzychem Lifesciences Recent Developments/Updates
Table 102. Enzychem Lifesciences Competitive Strengths & Weaknesses
Table 103. Humanetics Basic Information, Manufacturing Base and Competitors
Table 104. Humanetics Major Business
Table 105. Humanetics Anti-radiation Drugs Product and Services
Table 106. Humanetics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Humanetics Recent Developments/Updates
Table 108. Humanetics Competitive Strengths & Weaknesses
Table 109. Mission Pharmacal Basic Information, Manufacturing Base and Competitors
Table 110. Mission Pharmacal Major Business
Table 111. Mission Pharmacal Anti-radiation Drugs Product and Services
Table 112. Mission Pharmacal Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mission Pharmacal Recent Developments/Updates
Table 114. Mission Pharmacal Competitive Strengths & Weaknesses
Table 115. Partner Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Partner Therapeutics Major Business
Table 117. Partner Therapeutics Anti-radiation Drugs Product and Services
Table 118. Partner Therapeutics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Partner Therapeutics Recent Developments/Updates
Table 120. Partner Therapeutics Competitive Strengths & Weaknesses
Table 121. Myelo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Myelo Therapeutics Major Business
Table 123. Myelo Therapeutics Anti-radiation Drugs Product and Services
Table 124. Myelo Therapeutics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Myelo Therapeutics Recent Developments/Updates
Table 126. Pluri Basic Information, Manufacturing Base and Competitors
Table 127. Pluri Major Business
Table 128. Pluri Anti-radiation Drugs Product and Services
Table 129. Pluri Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Anti-radiation Drugs Upstream (Raw Materials)
Table 131. Anti-radiation Drugs Typical Customers
Table 132. Anti-radiation Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Anti-radiation Drugs Picture
Figure 2. World Anti-radiation Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Anti-radiation Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 5. World Anti-radiation Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Anti-radiation Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Anti-radiation Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 10. China Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 12. Anti-radiation Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Anti-radiation Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Anti-radiation Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-radiation Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-radiation Drugs Markets in 2022
Figure 26. United States VS China: Anti-radiation Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Anti-radiation Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Anti-radiation Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Anti-radiation Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Anti-radiation Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Anti-radiation Drugs Production Market Share 2022
Figure 32. World Anti-radiation Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Anti-radiation Drugs Production Value Market Share by Type in 2022
Figure 34. Potassium lodide (KI)
Figure 35. Prussian Blue
Figure 36. DTPA (Diethylenetriamine Pentaacetate)
Figure 37. Others
Figure 38. World Anti-radiation Drugs Production Market Share by Type (2018-2029)
Figure 39. World Anti-radiation Drugs Production Value Market Share by Type (2018-2029)
Figure 40. World Anti-radiation Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Anti-radiation Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Anti-radiation Drugs Production Value Market Share by Application in 2022
Figure 43. Acute Radiation Syndrome(ARS)
Figure 44. Cancer Treatment
Figure 45. Radiation Exposure
Figure 46. Others
Figure 47. World Anti-radiation Drugs Production Market Share by Application (2018-2029)
Figure 48. World Anti-radiation Drugs Production Value Market Share by Application (2018-2029)
Figure 49. World Anti-radiation Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Anti-radiation Drugs Industry Chain
Figure 51. Anti-radiation Drugs Procurement Model
Figure 52. Anti-radiation Drugs Sales Model
Figure 53. Anti-radiation Drugs Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Anti-radiation Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Anti-radiation Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Anti-radiation Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Anti-radiation Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Anti-radiation Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Anti-radiation Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Anti-radiation Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Anti-radiation Drugs Production Market Share by Region (2018-2023)
Table 9. World Anti-radiation Drugs Production Market Share by Region (2024-2029)
Table 10. World Anti-radiation Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Anti-radiation Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Anti-radiation Drugs Major Market Trends
Table 13. World Anti-radiation Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Anti-radiation Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Anti-radiation Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Anti-radiation Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Anti-radiation Drugs Producers in 2022
Table 18. World Anti-radiation Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Anti-radiation Drugs Producers in 2022
Table 20. World Anti-radiation Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Anti-radiation Drugs Company Evaluation Quadrant
Table 22. World Anti-radiation Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Anti-radiation Drugs Production Site of Key Manufacturer
Table 24. Anti-radiation Drugs Market: Company Product Type Footprint
Table 25. Anti-radiation Drugs Market: Company Product Application Footprint
Table 26. Anti-radiation Drugs Competitive Factors
Table 27. Anti-radiation Drugs New Entrant and Capacity Expansion Plans
Table 28. Anti-radiation Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Anti-radiation Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Anti-radiation Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Anti-radiation Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-radiation Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Anti-radiation Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Anti-radiation Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Anti-radiation Drugs Production Market Share (2018-2023)
Table 37. China Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-radiation Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Anti-radiation Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Anti-radiation Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Anti-radiation Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Anti-radiation Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-radiation Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-radiation Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Anti-radiation Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-radiation Drugs Production Market Share (2018-2023)
Table 47. World Anti-radiation Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Anti-radiation Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Anti-radiation Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Anti-radiation Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Anti-radiation Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Anti-radiation Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Anti-radiation Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Anti-radiation Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Anti-radiation Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Anti-radiation Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Anti-radiation Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Anti-radiation Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Anti-radiation Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Anti-radiation Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Anti-radiation Drugs Product and Services
Table 64. Amgen Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Anbex Basic Information, Manufacturing Base and Competitors
Table 68. Anbex Major Business
Table 69. Anbex Anti-radiation Drugs Product and Services
Table 70. Anbex Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Anbex Recent Developments/Updates
Table 72. Anbex Competitive Strengths & Weaknesses
Table 73. BTG International Basic Information, Manufacturing Base and Competitors
Table 74. BTG International Major Business
Table 75. BTG International Anti-radiation Drugs Product and Services
Table 76. BTG International Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BTG International Recent Developments/Updates
Table 78. BTG International Competitive Strengths & Weaknesses
Table 79. Cellphire Basic Information, Manufacturing Base and Competitors
Table 80. Cellphire Major Business
Table 81. Cellphire Anti-radiation Drugs Product and Services
Table 82. Cellphire Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Cellphire Recent Developments/Updates
Table 84. Cellphire Competitive Strengths & Weaknesses
Table 85. Chrysalis BioTherapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Chrysalis BioTherapeutics Major Business
Table 87. Chrysalis BioTherapeutics Anti-radiation Drugs Product and Services
Table 88. Chrysalis BioTherapeutics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Chrysalis BioTherapeutics Recent Developments/Updates
Table 90. Chrysalis BioTherapeutics Competitive Strengths & Weaknesses
Table 91. Darnitsa Basic Information, Manufacturing Base and Competitors
Table 92. Darnitsa Major Business
Table 93. Darnitsa Anti-radiation Drugs Product and Services
Table 94. Darnitsa Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Darnitsa Recent Developments/Updates
Table 96. Darnitsa Competitive Strengths & Weaknesses
Table 97. Enzychem Lifesciences Basic Information, Manufacturing Base and Competitors
Table 98. Enzychem Lifesciences Major Business
Table 99. Enzychem Lifesciences Anti-radiation Drugs Product and Services
Table 100. Enzychem Lifesciences Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Enzychem Lifesciences Recent Developments/Updates
Table 102. Enzychem Lifesciences Competitive Strengths & Weaknesses
Table 103. Humanetics Basic Information, Manufacturing Base and Competitors
Table 104. Humanetics Major Business
Table 105. Humanetics Anti-radiation Drugs Product and Services
Table 106. Humanetics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Humanetics Recent Developments/Updates
Table 108. Humanetics Competitive Strengths & Weaknesses
Table 109. Mission Pharmacal Basic Information, Manufacturing Base and Competitors
Table 110. Mission Pharmacal Major Business
Table 111. Mission Pharmacal Anti-radiation Drugs Product and Services
Table 112. Mission Pharmacal Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mission Pharmacal Recent Developments/Updates
Table 114. Mission Pharmacal Competitive Strengths & Weaknesses
Table 115. Partner Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Partner Therapeutics Major Business
Table 117. Partner Therapeutics Anti-radiation Drugs Product and Services
Table 118. Partner Therapeutics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Partner Therapeutics Recent Developments/Updates
Table 120. Partner Therapeutics Competitive Strengths & Weaknesses
Table 121. Myelo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Myelo Therapeutics Major Business
Table 123. Myelo Therapeutics Anti-radiation Drugs Product and Services
Table 124. Myelo Therapeutics Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Myelo Therapeutics Recent Developments/Updates
Table 126. Pluri Basic Information, Manufacturing Base and Competitors
Table 127. Pluri Major Business
Table 128. Pluri Anti-radiation Drugs Product and Services
Table 129. Pluri Anti-radiation Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Anti-radiation Drugs Upstream (Raw Materials)
Table 131. Anti-radiation Drugs Typical Customers
Table 132. Anti-radiation Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Anti-radiation Drugs Picture
Figure 2. World Anti-radiation Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Anti-radiation Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 5. World Anti-radiation Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Anti-radiation Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Anti-radiation Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 10. China Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Anti-radiation Drugs Production (2018-2029) & (K Units)
Figure 12. Anti-radiation Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Anti-radiation Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Anti-radiation Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Anti-radiation Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-radiation Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-radiation Drugs Markets in 2022
Figure 26. United States VS China: Anti-radiation Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Anti-radiation Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Anti-radiation Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Anti-radiation Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Anti-radiation Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Anti-radiation Drugs Production Market Share 2022
Figure 32. World Anti-radiation Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Anti-radiation Drugs Production Value Market Share by Type in 2022
Figure 34. Potassium lodide (KI)
Figure 35. Prussian Blue
Figure 36. DTPA (Diethylenetriamine Pentaacetate)
Figure 37. Others
Figure 38. World Anti-radiation Drugs Production Market Share by Type (2018-2029)
Figure 39. World Anti-radiation Drugs Production Value Market Share by Type (2018-2029)
Figure 40. World Anti-radiation Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Anti-radiation Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Anti-radiation Drugs Production Value Market Share by Application in 2022
Figure 43. Acute Radiation Syndrome(ARS)
Figure 44. Cancer Treatment
Figure 45. Radiation Exposure
Figure 46. Others
Figure 47. World Anti-radiation Drugs Production Market Share by Application (2018-2029)
Figure 48. World Anti-radiation Drugs Production Value Market Share by Application (2018-2029)
Figure 49. World Anti-radiation Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Anti-radiation Drugs Industry Chain
Figure 51. Anti-radiation Drugs Procurement Model
Figure 52. Anti-radiation Drugs Sales Model
Figure 53. Anti-radiation Drugs Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
